Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

56.57
Delayed Data
As of Apr 21
 -0.16 / -0.28%
Today’s Change
36.71
Today|||52-Week Range
62.50
+1.78%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close56.73
Today’s open56.74
Day’s range56.07 - 57.30
Volume738,838
Average volume (3 months)816,555
Market cap$8.7B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+152.40%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.13

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.38-0.89%
SGENSeattle Genetics Inc-1.70-2.54%
PRGOPerrigo Company PLC-0.33-0.49%
TSROTESARO Inc-3.00-2.16%
Data as of 4:02pm ET, 04/21/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs